Articles tagged with Lung Cancer
A study of 2 million people and 22 cancer registries found that African Americans and Asians living outside the US have higher death rates from lung cancer than Europeans. Lung cancer risk among never smokers is not increasing, contradicting previous research.
Researchers developed a new model specifically for African-American populations, refining lung cancer risk prediction with unique results based on increased exposure to risks. The study also expanded the original Spitz model by adding DNA repair capacity measures, improving predictive capability.
Researchers have identified African-Americans as having a greater risk of developing lung cancer from chronic obstructive pulmonary disease (COPD), with a more than sixfold increased risk. Hay fever was also found to be protective among African-Americans, reducing the risk by 44%.
A study published in Journal of Consumer Research found that simply asking people if they're willing to volunteer their time leads to increased donations of both time and money. This effect cannot be explained by guilt or feelings of obligation, suggesting a deeper psychological connection between giving time and experiencing happiness.
A combination of S-1 and irinotecan appears to offer a promising alternative to standard treatment for advanced non-small cell lung cancer, with similar response rates and progression-free survival. The experimental therapy resulted in less severe side effects compared to platinum-based chemotherapy regimens.
A gene expression test could help determine which patients need more aggressive treatment, improving lung cancer survival rates. The study used a large dataset of lung cancer tissue samples to analyze hundreds of genes and predict patient outcomes.
Research suggests that passive smoking poses a significant risk to lung cancer development, with sidestream smoke potentially more carcinogenic than mainstream smoke. The study proposes using DNA-lesion footprinting and mutagenicity analysis to identify unique biological markers for assessing lung cancer risk in relation to SHS exposure.
Research finds that smokeless tobacco products carry a lower cancer risk compared to smoking, particularly for oral and oesophageal cancers. However, users are still at increased risk of other types of cancer, such as lung cancer, especially in countries with high STP use.
Smoke-free policies are reducing heart disease related to smoke exposure, prevalence of smoking in adults, and second-hand smoke exposure. These policies also increase smoke-free environments and have benefits for non-smokers.
A study published in The Lancet Oncology found that radiofrequency ablation can be an effective treatment for small lung tumors, with a confirmed complete response rate of 88% and overall survival rates ranging from 48-75%. The procedure was also shown to have a low risk of complications, including pneumothorax and pleural effusion.
A recent study published in The Lancet Oncology found that smoking does not increase the risk of lung cancer in women compared to men. However, women who have never smoked are at higher risk of developing lung cancer than men who have never smoked.
A new study suggests that CT lung cancer screening can increase lung cancer detection by 37% and reduce mortality by 28%, but has limited impact on all-cause mortality. Quitting smoking is still the most effective way to reduce risk of death from various causes.
A team of researchers from the University of Leeds has made a breakthrough in understanding finger clubbing by identifying its link to lung cancer. The team discovered that a genetic mutation prevents the breakdown of fatty compound PGE2, leading to swollen fingers and fingernails.
Researchers at the University of Pennsylvania's CEET have discovered that polycyclic aromatic hydrocarbons (PAHs) can lead to mutations in critical genes in lung cancer through oxidative stress. PAHs transform into oxygen free radicals, which bind to DNA and cause damage if not repaired.
UCLA researchers found that smokers who ingested high levels of flavonoids had a lower risk of developing lung cancer. Flavonoids are water-soluble plant pigments with antioxidant and anti-inflammatory properties.
Researchers found that carrying alpha-1 antitrypsin deficiency increases lung cancer risk in smokers and nonsmokers, with the genetic disorder explaining up to 12% of lung cancer patients. Individuals who carry the gene should be screened for lung cancer and avoid potential carcinogens.
A genetic disorder previously associated with lung disease may also increase lung cancer risk, according to a study. Researchers found that carriers of the disorder had a 70-100% increased risk of lung cancer compared to non-carriers.
Research found that individuals with gum disease have an increased risk of various cancers, including lung, kidney, and pancreatic cancers. Gum disease was associated with a 14% higher overall cancer risk compared to those without gum disease.
Researchers developed a blood test that can detect lung cancer in its earliest stages with high accuracy, potentially eliminating the need for invasive biopsies. The test uses gene expression analysis of circulating white blood cells and showed an 87% accuracy rate.
A new study led by Duke University researchers found that lung cancer patients can tolerate exercise after surgery, leading to improved tolerance for physical activity and better overall quality of life. The 14-week study showed significant gains in aerobic fitness and reduced fatigue among participants.,
A first-of-its-kind lung cancer chemoprevention trial found Celebrex reduces precancerous lesion proliferation and is safe for high-risk individuals. The study demonstrated the importance of COX-2 inhibition in preventing lung cancer, with potential implications for cancer prevention and treatment.
Researchers pinpointed the protein FANCD2 as slowed production leads to genetic changes triggering lung cancer. Low levels of FANCD2 cause DNA damage and faulty cells committing suicide.
Women who quit smoking experience a significant reduction in mortality risk, with 61% of the benefit realized within 5 years for coronary heart disease and 42% for cerebrovascular mortality. Quitting also reduces lung cancer mortality risk by 21% within 5 years, with an 87% reduction after 20-30 years.
A new study published in the Journal of the National Cancer Institute estimates that Medicare costs for elderly cancer patients will top $21.1 billion over a 5-year period. The estimated cost varies widely depending on tumor type, stage at diagnosis, and phase of care.
A new online database provides a comprehensive list of somatic EGFR mutations, allowing clinicians to make more robust decisions about treatment options for non-small-cell lung cancer patients. The database includes data from thousands of patients and offers improved treatment outcomes for those receiving tyrosine kinase inhibitors.
A new clinical trial found that MAGE-A3 ASCI reduces the risk of lung cancer relapse after surgery, similar to chemotherapy but with fewer side effects. The treatment, which boosts the immune system, showed minimal reactions at injection sites and was suitable for long-term maintenance treatment.
Research suggests common viruses, such as human papillomavirus (HPV) and measles virus, may play a role in lung cancer development, particularly in smokers. Studies have found that five out of 22 non-small-cell lung cancer samples were positive for HPV.
Researchers found that nicotine increases osteopontin production, promoting cancer cell survival and spread. Elevated osteopontin levels have been detected in pancreatic cancer patients, suggesting a potential role in the cigarette smoking-pancreatic cancer connection.
A study at the University of Texas M. D. Anderson Cancer Center found that oral tissue can be used to monitor molecular events in less accessible lung tissue. The research discovered that cells lining the mouth reflect the same antitumor genes silenced in oral and lung tissue, offering a new approach to detecting lung cancer.
A large-scale study has found a specific gene variant that increases the risk of lung cancer. The researchers also discovered a connection between this gene and nicotine dependence, as well as smoking behavior.
A recent study has identified two common genetic variants associated with an increased risk of lung cancer in smokers and former smokers. The variants, present in about half of the Caucasian population, were found to increase the risk by 28-81%.
Researchers at Boston University School of Medicine have developed a clinicogenomic model to test for lung cancer with increased sensitivity and specificity. The model combines gene expression and clinical risk factors, offering improved accuracy in identifying patients who would benefit from further invasive testing.
A new study published in Health Physics found that exposure to low levels of radon gas may reduce the risk of developing lung cancer, with a 60% reduction observed at certain levels. The study involved nearly 600 Massachusetts homes and adjusted for factors such as smoking and education.
Researchers at Yale University and Asuragen, Inc. found that the microRNA let-7 substantially reduced cancer growth in multiple mouse models of lung cancer, indicating a direct role for miRNAs in cancer progression. The study introduces a new paradigm for using miRNAs as effective therapeutic agents to treat human cancer.
Dr. Adam Marcus receives $80,000 award to study lung cancer cell invasion and mutations of the LKB1 protein. This research could lead to novel diagnostic and prognostic approaches to control lung cancer malignancy.
Two researchers, Hildegard Schuller and Albert Baldwin, received funding for studies on sex differences in lung cancer and the regulation of normal cell growth. The grants aim to increase understanding of lung cancer and support scientists pursuing lung cancer research.
AstraZeneca's investigational cancer drug vandetanib has completed patient enrollment in two pivotal Phase III studies for the second-line treatment of non-small cell lung cancer. The ZODIAC and ZEAL studies aim to assess the efficacy of vandetanib in combination with chemotherapy treatments.
Scientists have discovered specific methylation patterns in tumors and tissue that can predict which lung cancers are more likely to recur. These patterns could lead to reclassifying small lung cancers as advanced disease, allowing for more aggressive treatment options.
A study published by the American Thoracic Society found that certain vitamin supplements, including multivitits, vitamin C, and folate, did not protect against lung cancer and may even increase the risk. The risk was highest among current smokers, with a seven percent rise in risk for every 100mg/day of supplemental vitamin E.
Researchers identify hydrogen peroxide in cigarette smoke as a primary cause of lung cancer development. The study may lead to the development of 'safer' cigarettes and new treatments for lung cancer.
A University of Florida study found that the protein Bc12 blocks DNA repair in lung cancer cells, allowing them to thrive despite damage from radiation or chemicals. The discovery provides a new understanding of how lung cancer cells evade treatments, offering potential targets for drug development.
The National Lung Cancer Partnership has partnered with three organizations to co-sponsor new lung cancer research grants, focusing on survivorship care and nursing-sensitive patient outcomes. This move aims to address the lack of research funding for lung cancer, a leading cancer killer in the US.
Researchers at The Wistar Institute have solved the structure of p300/CBP, a gene regulator implicated in deadliest cancers. The breakthrough reveals how p300/CBP regulates a wide variety of genes and enables the development of targeted cancer therapies.
A multi-institutional study found PET more reliable than CT in characterizing lung nodules as malignant. PET's superior specificity led to correctly classifying 58% of benign nodules misclassified on CT.
Researchers at Mayo Clinic have developed a new technique using two small flexible tubes to stage lung cancer, achieving a 93% accuracy rate in finding malignant lymph nodes. This method is less invasive and more precise than traditional surgical methods, allowing patients to recover the same day.
A study suggests that endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) and its combination with endobronchial ultrasound-guided fine-needle aspiration (EBUS-FNA) can accurately determine lung cancer stage. These minimally invasive methods show high sensitivity rates, potentially replacing traditional surgical procedures.
A vaccine booster has been shown to induce a persistent immune response against lung cancer, reducing the risk of recurrence. The study found that patients who received regular recall injections experienced improved immunological memory, which can be strengthened with additional vaccinations.
Researchers at UCLA's Jonsson Cancer Center have discovered biomarkers that can help personalize treatment for patients with advanced non-small cell lung cancer. These biomarkers may identify patients who will respond to the Celebrex and Tarceva combination therapy, sparing them from ineffective treatments.
A $100,000 grant from Joan's Legacy will enable Cold Spring Harbor Laboratory to build upon recent lung cancer discoveries, focusing on epidermal growth factor receptors (EGFR) and their potential link to estrogen. The research aims to understand how EGFR genetic mutations contribute to non-small cell lung cancer development.
Scientists at UAB have identified a new lung cancer marker, AKR1B10, which can appear even before cancer develops. The enzyme's activity may play a role in the development of lung cancer and could be targeted by future treatments.
Researchers have identified a key gene, 14-3-3zeta, that enables lung cancer cells to survive on their own. Silencing this gene has been shown to inhibit the growth and survival of lung cancer cells, making it a potential target for selective anti-cancer drugs.
A study by Indiana University researchers found that receiving primary care during cancer treatment improves cancer survival rates, especially in lung cancer patients. Primary care utilization increased median survival rates by over fourfold, highlighting the importance of comprehensive care for whole-person health.
A new study published in PLoS Medicine found that consuming high amounts of red and processed meats increases the risk of developing bowel and lung cancer. The research, conducted by Amanda Cross and colleagues, analyzed data from a large US diet and health study involving nearly half a million men and women aged 50-71.
Researchers found that eating veggies, gardening, and being physically active can reduce lung cancer risk in smokers and non-smokers. Additionally, a study suggests men are more prone to developing skin cancers due to differences in antioxidant levels and DNA repair capacity.
Researchers at Duke University Medical Center have identified four blood proteins that can distinguish patients with lung cancer from those without. The blood test, which uses a classification tree to sort out likelihoods, shows promise as a less-invasive follow-up for patients with suspicious lesions.
Researchers at M.D. Anderson Cancer Center link diet and gardening to lung cancer risk reduction, finding that smokers and nonsmokers can reduce their risk by eating four or more servings of green salad a week and working in the garden once or twice a week.
A new study published in JCI Journal has found that CP-31398, a compound that binds to mutant forms of the p53 protein, can prevent and treat UV light–induced skin cancers in mice. The study also demonstrated that CP-31398 increased p53 function in human skin cancer cells expressing a mutant form of p53.
A five-year study will evaluate the performance of chest X-ray CAD in identifying hard-to-detect lung cancers, aiming to improve patient survival rates. The study, funded by the State of Ohio, will involve 9,000 test subjects and assess the software's ability to identify actionable pulmonary nodules.
A study by Dartmouth researchers found that rural patients are diagnosed at an earlier stage for colorectal and lung cancer compared to urban patients. The study controlled for various factors, including age, race, and education level. Rural-urban differences in cancer presentation may inform targeted screening efforts.
A comprehensive review by the UK National Health Service found that PET scans can help diagnose and treat certain types of cancer more accurately than other imaging technologies. However, it is unclear whether these advances lead to improved patient outcomes and survival rates.